Astrasana Holding AG is pursuing the goal of building a European distribution network of medical cannabis.
CEO Yves Antoniazzi, his subsidiary Astrasana Czech s.r.o with its’ managing director Tomas Ryska, are setting their sights on the next European country, the Czech Republic: “We are entering into a joint venture with the pharmaceutical company Pilulka s.r.o.
“This gives us access to the Czech market and an existing patient base. Together, we have planned for the import and distribution of pharmaceutical raw materials. As the legalisation of medical cannabis progresses throughout Europe, new markets are gradually opening up, and we are in a prime position to tap into them.”
Co-Founder Miroslav Šmida is responsible for Pilulka s.r.o.. His company operates a large hospital pharmacy in the city of Brno and already serves thousands of patients. Medical hemp has been legal in the country since 2014 but is still difficult to obtain. In 2022, cannabis extracts were authorised for medical therapies and this need can now be met with imported APIs.
